FDG PET in Neurological Manifestations of COVID-19.


Journal

Clinical nuclear medicine
ISSN: 1536-0229
Titre abrégé: Clin Nucl Med
Pays: United States
ID NLM: 7611109

Informations de publication

Date de publication:
01 Apr 2024
Historique:
medline: 1 4 2024
pubmed: 1 4 2024
entrez: 1 4 2024
Statut: aheadofprint

Résumé

Both the central and peripheral nervous systems can be affected in COVID-19. Although MRI is the primary investigative tool for neurological imaging, FDG PET may show additional areas of involvement in the brain in the form of regional hypometabolism or hypermetabolism, secondary to synaptic dysfunction and electrical or glial activation. We present a case series of 4 patients who had neurological symptoms attributable to COVID-19 infection with abnormalities in the brain FDG PET scan.

Identifiants

pubmed: 38557407
doi: 10.1097/RLU.0000000000005187
pii: 00003072-990000000-01044
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Informations de copyright

Copyright © 2024 Wolters Kluwer Health, Inc. All rights reserved.

Déclaration de conflit d'intérêts

Conflicts of interest and sources of funding: none declared.

Références

Zubair AS, McAlpine LS, Gardin T, et al. Neuropathogenesis and neurologic manifestations of the coronaviruses in the age of coronavirus disease 2019: a review. JAMA Neurol. 2020;77:1018–1027.
Mao L, Jin H, Wang M, et al. Neurologic manifestations of hospitalized patients with coronavirus disease 2019 in Wuhan, China. JAMA Neurol. 2020;77:683–690.
Karadaş Ö, Öztürk B, Sonkaya AR. A prospective clinical study of detailed neurological manifestations in patients with COVID-19. Neurol Sci. 2020;41:1991–1995.
Helms J, Kremer S, Merdji H, et al. Neurologic features in severe SARS-CoV-2 infection. N Engl J Med. 2020;382:2268–2270.
Paterson RW, Brown RL, Benjamin L, et al. The emerging spectrum of COVID-19 neurology: clinical, radiological and laboratory findings. Brain. 2020;143:3104–3120.
Garg RK. Spectrum of neurological manifestations in COVID-19: a review. Neurol India. 2020;68:560–572.
Pezzini A, Padovani A. Lifting the mask on neurological manifestations of COVID-19. Nat Rev Neurol. 2020;16:636–644.
SM Cho, N White, L Premraj, et al. Neurological manifestations of COVID-19 in adults and children. Brain, 2023;146: 1648–1661.

Auteurs

Ritu Verma (R)

Department of Nuclear Medicine & PET/CT, Mahajan Imaging & labs, Sir Ganga Ram Hospital.

Rajeev Ranjan (R)

Department of Neurology, Sir Ganga Ram Hospital, New Delhi, India.

Ethel Belho (E)

Department of Nuclear Medicine & PET/CT, Mahajan Imaging & labs, Sir Ganga Ram Hospital.

Classifications MeSH